Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Sinclair III Eric L. (Ric)Chief Business Officer | Option exercise · 10b5-1 plan | M | $138K 7,562 sh |
| Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 1,000 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Capital V LLC10% Owner | Option exercise · 10b5-1 plan | M | — 37.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Smith J. JeffersonChief Research Officer | Option exercise · 10b5-1 plan | M | — 10.4K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | $107K 15.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Gibson ChristopherDirector | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Ahn KennethPresident, Hagerty Marketplace | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | Option exercise · 10b5-1 plan | M | — 3,386 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Sheena JonathanDirector, CO-FOUNDER | Option exercise · 10b5-1 plan | M | — 191 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | O'Connor CaseyChief Legal Officer | Option exercise · 10b5-1 plan | M | — 13.9K sh | Jan 22, 2026 traded Jan 21, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Sinclair III Eric L. (Ric)Chief Business Officer | Option exercise · 10b5-1 plan | M | — 32.7K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 8,335 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Option exercise · 10b5-1 plan | M | — 856 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Smith J. JeffersonChief Research Officer | Option exercise · 10b5-1 plan | M | — 2,500 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Option exercise · 10b5-1 plan | M | — 856 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 1,000 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Kelly John AlexanderChief Financial Officer | Option exercise · 10b5-1 plan | M | — 3,888 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 25.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 1,522 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 102.8K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 44.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 62 | Brakewood Harold EugeneChief Business Officer | Open-market purchase | BUY | $25K 5,250 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 52 | Marantz Jing L.CHIEF MEDICAL OFFICER | Open-market sale | SELL | $258K 5,798 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Ho JunlinGENERAL COUNSEL | Open-market sale | SELL | $357K 8,016 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Parlavecchio CarynCHRO | Open-market sale | SELL | $294K 6,600 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $15.09M 12.9K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Open-market sale | SELL | $374K 8,406 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 45 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $6.46M 5,514 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 45 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $9.54M 8,139 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 36 | Attal AlainDirector | Open-market purchase | BUY | $260K 12.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 35 | Small MartinCFO & Senior Managing Director | Option exercise | M | $13.89M 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 34 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $590K 503 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 33 | Harmon CyrusDirector | Open-market sale | SELL | $269K 10.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 31 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Option exercise | M | — 1,250 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 30 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $202K 27.2K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 30 | Exicure HiTron Inc.10% Owner | Open-market sale | SELL | $1.16M 258.4K sh | Jan 21, 2026 traded Jan 21, 2026 |